Insight Lifetech, a portfolio company of Qiming Venture Partners and a leading Chinese innovative medical device manfaucturer, successfully listed on the Shanghai Stock Exchange's STAR Market on ...

The medical device innovator completed its initial public offering on Shanghai's science and technology board.

EDEN PRAIRIE, Minn., Paul Teirstein, MD, the chief of cardiology and director of interventional cardiology for Scripps Clinic and director of the Scripps Prebys Cardiovascular Institute for Scripps ...

“There was some debate about IVUS many years ago, but then randomized controlled trials came out, as well as other observational studies, to show that it is effective in optimizing post-PCI results, ...